Using data from the 2022 National Agricultural Workers Survey (NAWS), this issue brief examines key characteristics of agricultural workers, including their citizenship status, health coverage, and access to health care. The Trump administration’s restrictive immigration policies may compound health challenges and risks this groups faces and have negative impacts on the cost and availability of…
We urgently need biomarkers that are sensitive, objective, and practical. Eye-movement measures are ready to fill this gap, not as distant innovations, but as tools available today. The post More Than Meets the Eye: Using Eye Movements in Drug Development for Neurodegenerative Diseases appeared first on MedCity News.
Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on…
By actively and consistently collecting feedback, hospitals can gain rapid insights into critical areas, allowing them to track and measure patient satisfaction levels, and crucially to react to any dips in standards of care. The post How Data Feedback Can Aid Patient Experience in Healthcare appeared first on MedCity News.
Cigna’s new digital tools include an AI-powered virtual assistant, personalized provider matching and cost tracking. The post Cigna Launches 6 New Digital Tools To Improve Customer Experience appeared first on MedCity News.
Our industry must guard against the weaponization of supply chain resilience in healthcare purchasing. The post Health Systems’ Escalating Demands for Supply Chain Resilience Have Become Counterproductive appeared first on MedCity News.
Patient flow automation startup Qventus closed a $105 million Series D financing round. The company’s technology is used by more than 115 hospitals and health systems, including Northwestern Medicine, Banner Health and Allina Health. The post Qventus Snags $105M for Its Patient Flow Automation Tech appeared first on MedCity News.
Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for familial chylomicronemia syndrome, an inherited lipid disorder. Beyond its claims of safety and dosing advantages, Arrowhead set a dramatically lower price for its first commercial product, which will compete against an Ionis Pharmaceuticals drug. The post With FDA Approval for…
Policymakers should recognize the advantages of this multi-faceted care model and ensure legislative and regulatory environments allow for its continued growth. The post Prioritizing Care That Cures – Fighting the Epidemic With Opioid Treatment Programs appeared first on MedCity News.
By ARIEL FRISTOE As the artistic director of Out of Hand Theater, an arts organization that promotes anti-racism, social activism and health equity, I believe the recent appointment of Robert F. Kennedy, Jr. (RFK) as Secretary to the Department of Health and Human Services is beyond concerning. RFK is not a doctor, nor is he…